Consolidated figures
| Ratio | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Margins | ||||
| Gross margin % | 40.6% | 49.7% | 52.2% | 55.1% |
| EBITDA margin % | 8.3% | 22.5% | ||
| 27% |
| 25.2% |
| EBIT margin % | 4.7% | 20% | 25% | 22.8% |
| PAT margin % | -0.6% | 11.3% | 17.4% | 16.1% |
| Working capital | ||||
| Receivable days | 57 | 68 | 98 | 104 |
| Inventory days | 543 | 469 | 378 | 453 |
| Payable days | 273 | 201 | 172 | 198 |
| NWC days | 327 | 336 | 304 | 359 |
| Leverage | ||||
| Current ratio | 0.93 | 2.47 | 2.15 | 2.26 |
| Debt to EBITDA | 10.87 | 1.01 | 1.01 | 1.61 |
| Debt to equity | 10.18 | 0.22 | 0.29 | 0.42 |
| Interest coverage | 0.7 | 3.1 | 11.1 | 7.7 |
| Asset turnover | 0.61 | 0.61 | 0.65 | 0.58 |
| Return ratios | ||||
| Return on assets % | -0.4% | 6.9% | 11.3% | 9.3% |
| Return on capital employed % | 27.5% | 32.2% | 28.7% | 25.3% |
| Return on equity % | -6.7% | 11.1% | 18.7% | 16.8% |
Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.